Opus Investment Management Inc Gilead Sciences, Inc. Transaction History

Opus Investment Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $3.27 Million - $4.7 Million	-52,500 Reduced 77.43%	15,300 $1.31 Million
Q1 2022 May 11, 2022	BUY	$57.92 - $72.58 $434,400 - $544,350	7,500 Added 12.44%	67,800 $4.03 Million
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $3.83 Million - $4.18 Million	60,300 New	60,300 $4.15 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Opus Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Opus Investment Management Inc with notifications on news.